BIO board met with US officials on China, CEO saysnews2026-06-23T18:18:50+00:00June 23rd, 2026|Endpoints News|
Trump backs psychedelics, but CDMOs hold back for nownews2026-06-23T16:00:33+00:00June 23rd, 2026|Endpoints News|
Pfizer late-stage ADC lung cancer fail calls cancer strategy into questionnews2026-06-23T14:44:59+00:00June 23rd, 2026|Endpoints News|
Exelixis’ zanzalintinib falls short in colorectal cancer subgroupnews2026-06-23T11:05:40+00:00June 23rd, 2026|Endpoints News|
HHS launches broad effort to expand and speed up clinical trialsnews2026-06-22T18:45:17+00:00June 22nd, 2026|Endpoints News|
After ‘redesign,’ WuXi Biologics sets new timeline for Massachusetts factory completionnews2026-06-22T15:40:54+00:00June 22nd, 2026|Endpoints News|
Regenxbio to resubmit Hunter syndrome gene therapy without new studynews2026-06-22T11:14:56+00:00June 22nd, 2026|Endpoints News|
AbbVie makes $10.9B move for Apogee’s long-acting I&I drug candidatesnews2026-06-22T11:03:23+00:00June 22nd, 2026|Endpoints News|
Sanofi R&D leader Houman Ashrafian to depart, Paulo Fontoura to take the reinsnews2026-06-22T10:50:34+00:00June 22nd, 2026|Endpoints News|
US government launches probe into Germany’s plan to pay less for drugs news2026-06-19T12:36:13+00:00June 19th, 2026|Endpoints News|
